Total planned funding: $124,923,686
Allocations
Countries/Regions
India | $124,923,686 |
Organizational Types
Unknown | $48,517,074 |
NGO | $35,788,110 |
Own Agency | $19,393,299 |
University | $10,641,895 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
Multi-lateral Agency | $2,406,808 |
FBO | $1,100,000 |
Host Country Government Agency | $940,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $57,603,166 |
Prevention | $26,770,456 |
Management and Operations | $14,377,211 |
Care | $11,096,525 |
Treatment | $5,919,335 |
Testing | $4,729,201 |
Budget Codes
OHSS: Health Systems Strengthening | $35,197,804 |
HVSI: Strategic Information | $18,305,730 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,965,503 |
HVMS: Management and Operations | $14,377,211 |
HBHC: Care: Adult Care and Support | $5,679,474 |
HTXS: Treatment: Adult Treatment | $5,536,064 |
HVCT: Testing: HIV Testing and Counseling | $4,729,201 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,662,570 |
HLAB: Laboratory Infrastructure | $4,099,632 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,536,455 |
HKID: Care: Orphans and Vulnerable Children | $3,027,068 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,555,687 |
HVTB: Care: TB/HIV | $2,028,693 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDCS: Care: Pediatric Care and Support | $361,290 |
PDTX: Treatment: Pediatric Treatment | $359,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$47,892,585
Countries/Regions
FHI 360:
$16,690,357
Countries/Regions
USG Aggregated Agencies:
$9,702,094
Countries/Regions
Voluntary Health Services:
$5,750,000
Countries/Regions